100 related articles for article (PubMed ID: 23954439)
1. Reduced CNS exposure of memantine in a triple transgenic mouse model of Alzheimer's disease assessed using a novel LC-MS technique.
Mehta DC; Short JL; Nicolazzo JA
J Pharm Biomed Anal; 2013 Nov; 85():198-206. PubMed ID: 23954439
[TBL] [Abstract][Full Text] [Related]
2. Memantine transport across the mouse blood-brain barrier is mediated by a cationic influx H+ antiporter.
Mehta DC; Short JL; Nicolazzo JA
Mol Pharm; 2013 Dec; 10(12):4491-8. PubMed ID: 24098999
[TBL] [Abstract][Full Text] [Related]
3. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
[TBL] [Abstract][Full Text] [Related]
4. Method for measurement of the blood-brain barrier permeability in the perfused mouse brain: application to amyloid-beta peptide in wild type and Alzheimer's Tg2576 mice.
LaRue B; Hogg E; Sagare A; Jovanovic S; Maness L; Maurer C; Deane R; Zlokovic BV
J Neurosci Methods; 2004 Sep; 138(1-2):233-42. PubMed ID: 15325132
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N
Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665
[TBL] [Abstract][Full Text] [Related]
6. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
[TBL] [Abstract][Full Text] [Related]
7. Development of isotope labeling liquid chromatography mass spectrometry for mouse urine metabolomics: quantitative metabolomic study of transgenic mice related to Alzheimer's disease.
Peng J; Guo K; Xia J; Zhou J; Yang J; Westaway D; Wishart DS; Li L
J Proteome Res; 2014 Oct; 13(10):4457-69. PubMed ID: 25164377
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
[TBL] [Abstract][Full Text] [Related]
9. Lactoferrin Coupled Lower Generation PAMAM Dendrimers for Brain Targeted Delivery of Memantine in Aluminum-Chloride-Induced Alzheimer's Disease in Mice.
Gothwal A; Kumar H; Nakhate KT; Ajazuddin ; Dutta A; Borah A; Gupta U
Bioconjug Chem; 2019 Oct; 30(10):2573-2583. PubMed ID: 31553175
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of element profile changes induced by long-term dietary supplementation of zinc in the brain and cerebellum of 3xTg-AD mice by alternated cool and normal plasma ICP-MS.
Ciavardelli D; Consalvo A; Caldaralo V; Di Vacri ML; Nisi S; Corona C; Frazzini V; Sacchetta P; Urbani A; Di Ilio C; Sensi SL
Metallomics; 2012 Dec; 4(12):1321-32. PubMed ID: 23151739
[TBL] [Abstract][Full Text] [Related]
11. Folic Acid potentiates the effect of memantine on spatial learning and neuronal protection in an Alzheimer's disease transgenic model.
Chen TF; Huang RF; Lin SE; Lu JF; Tang MC; Chiu MJ
J Alzheimers Dis; 2010; 20(2):607-15. PubMed ID: 20164552
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of memantine on the retinal ganglion cells of APPswe/PS1ΔE9 mice and its immunomodulatory mechanisms.
Gao L; Chen X; Tang Y; Zhao J; Li Q; Fan X; Xu H; Yin ZQ
Exp Eye Res; 2015 Jun; 135():47-58. PubMed ID: 25912193
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
[TBL] [Abstract][Full Text] [Related]
14. Altered brain uptake of therapeutics in a triple transgenic mouse model of Alzheimer's disease.
Mehta DC; Short JL; Nicolazzo JA
Pharm Res; 2013 Nov; 30(11):2868-79. PubMed ID: 23794039
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation.
Kandimalla KK; Curran GL; Holasek SS; Gilles EJ; Wengenack TM; Poduslo JF
J Pharmacol Exp Ther; 2005 Jun; 313(3):1370-8. PubMed ID: 15743932
[TBL] [Abstract][Full Text] [Related]
16. Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD.
García-Barroso C; Ricobaraza A; Pascual-Lucas M; Unceta N; Rico AJ; Goicolea MA; Sallés J; Lanciego JL; Oyarzabal J; Franco R; Cuadrado-Tejedor M; García-Osta A
Neuropharmacology; 2013 Jan; 64():114-23. PubMed ID: 22776546
[TBL] [Abstract][Full Text] [Related]
17. Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease.
Luo F; Rustay NR; Ebert U; Hradil VP; Cole TB; Llano DA; Mudd SR; Zhang Y; Fox GB; Day M
Neurobiol Aging; 2012 May; 33(5):933-44. PubMed ID: 20961663
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of antidementia drugs on spatial learning and recall in the APP23 transgenic mouse model of Alzheimer's disease.
Neumeister KL; Riepe MW
J Alzheimers Dis; 2012; 30(2):245-51. PubMed ID: 22414570
[TBL] [Abstract][Full Text] [Related]
19. Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease.
Kulkarni PV; Roney CA; Antich PP; Bonte FJ; Raghu AV; Aminabhavi TM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(1):35-47. PubMed ID: 20049829
[TBL] [Abstract][Full Text] [Related]
20. Management of moderate to severe Alzheimer's disease: focus on memantine.
Dominguez E; Chin TY; Chen CP; Wu TY
Taiwan J Obstet Gynecol; 2011 Dec; 50(4):415-23. PubMed ID: 22212311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
